Nama's AI scorecard currently rates Innospec Buy (5.8 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is IOSP's P/E ratio?

Innospec trades at a trailing price-to-earnings ratio of 15.3.

When does IOSP report earnings?

Innospec's next scheduled report is on Feb 16, 2027. Analysts expect EPS of $1.41.

What is the IOSP price target?

The median analyst price target from 3 analysts is $100.00, with a range of $93.00 – $110.00.

Is IOSP Shariah compliant?

Nama's AAOIFI-style screen reads Innospec as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.

Does IOSP pay a dividend?

Yes — Innospec's dividend yield is 2.3%.

Nama Insights

Innospec (IOSP)

Basic Materials · Specialty Chemicals · NASDAQ

Innospec (IOSP) is a Basic Materials company in the Specialty Chemicals industry. It has a market capitalization of $1.93B, a trailing price-to-earnings ratio of 15.3 and a free-cash-flow yield of 3.2%. Over the most recent reported fiscal year, revenue declined 3.6% and free cash flow per share fell 48.4%. Nama's AI scorecard rates it Buy, 5.8 out of 10. On 12-month momentum it ranks in the rising band of its market.

AI scorecard

Buy · 5.8/10

Positive, at the low end of Buy. As of Nov 7, 2026.

Momentum

Rising · +32.6% over 12 months ex. last

Second-best fifth of its market on the past year's move.

Shariah screen

Shariah Compliant

Passes our debt, cash and income screen; not a scholar's ruling.

Off its high

-41.5%

How far the last close sits under the highest price of the past five years.

Market cap	$1.93B
Trailing P/E	15.3
Price / book	1.4
Price / sales	1.1
FCF yield	3.2%
Dividend yield	2.3%
Gross margin	27.5%
Operating margin	8.1%
Net margin	6.6%
Revenue growth (YoY)	-3.6%
Revenue growth (3-yr annual)	-3.3%
EPS growth (YoY)	-10.2%
FCF/share growth (YoY)	-48.4%
Beta	0.9
Exchange	NASDAQ
Sector	Basic Materials
Industry	Specialty Chemicals

IOSP earnings

Next report: Feb 16, 2027 (Q4 2026, EPS estimate $1.41). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Nov 3, 2026	$1.29	$1.26	+2.4%	$473.60M
Q2 2026	Aug 4, 2026	$1.27	$1.05	+20.9%	$491.40M
Q1 2026	May 7, 2026	$1.05	$1.01	+4.0%	$453.20M
Q4 2025	Feb 17, 2026	$1.50	$1.24	+21.0%	$455.60M

IOSP analyst price target

Median target $100.00 from 3 analysts, ranging $93.00 – $110.00.

Specialty Chemicals peers

Ticker	Company	Market cap	P/E
LIN	Linde	$236.54B	30.9
ECL	Ecolab	$84.33B	37.4
SHW	Sherwin-Williams	$83.13B	28.9
APD	Air Products and Chemicals	$67.88B	22.7
PPG	PPG Industries	$27.03B	15.7
IFF	International Flavors & Fragrances	$20.69B	22.3
LYB	LyondellBasell Industries	$19.63B	8.6
DD	DuPont de Nemours	$19.42B	20.9

Explore live IOSP data on Nama Insights →

IOSP FAQ

Is IOSP a buy?: Nama's AI scorecard currently rates Innospec Buy (5.8 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is IOSP's P/E ratio?: Innospec trades at a trailing price-to-earnings ratio of 15.3.
When does IOSP report earnings?: Innospec's next scheduled report is on Feb 16, 2027. Analysts expect EPS of $1.41.
What is the IOSP price target?: The median analyst price target from 3 analysts is $100.00, with a range of $93.00 – $110.00.
Is IOSP Shariah compliant?: Nama's AAOIFI-style screen reads Innospec as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.
Does IOSP pay a dividend?: Yes — Innospec's dividend yield is 2.3%.